Industry News
Basic research found to be underfunded in Australia
Australia is lagging behind similar countries in funding basic research, particularly in the medical, biotechnology and pharmaceutical sectors, according to a new study. [ + ]
Oral medication for Crohn's disease approved by FDA
Patients with moderate-to-severe Crohn's disease now have a new treatment option to suppress their intestinal inflammation and help them maintain their relief. [ + ]
Peptide modified to fight resistant bacteria
Researchers have modified the chemical structure of naturally occurring peptides to develop antimicrobial molecules that bind to novel targets in resistant bacteria's metabolism. [ + ]
A simple process for producing 2D materials
Surface scientists have developed a simple method to produce large and very clean 2D samples from a range of materials using three different substrates. [ + ]
Milestone as radio waves observed from Type Ia supernova
An international team of researchers performed detailed observations of a Type Ia supernova which exploded in 2020. [ + ]
Nanoparticle used to deliver brain cancer drug
The new silica nanoparticle can be loaded with temozolomide, a small molecule drug used to treat tumours known as glioblastoma. [ + ]
Predicting progression to life-threatening dengue fever
Scientists have discovered cell populations in blood which clearly indicate whether a person infected with dengue fever is likely to progress to life-threatening severe disease or not. [ + ]
Nominations open for 2023 GSK Award for Research Excellence
Nominations for one of the most prestigious and longstanding awards available to the Australian medical research community are now open for 2023. [ + ]
Euro Chemo-Pharma acquired by IMCD Malaysia
IMCD Malaysia has acquired Euro Chemo-Pharma with the aim of accelerating growth in life science markets. [ + ]
Potential brain cancer cure advances to clinical trial
A 'supercharged' version of QIMR Berghofer's CMV-specific T cell immunotherapy for brain cancer has advanced to a phase 1 clinical trial with CUREator funding. [ + ]
Trial of oral drug for radioactive contamination begins
The trial is designed to test the safety, tolerability and processing in the body of escalating doses of an experimental drug product in healthy adults. [ + ]
'Bioprospecting' for biological gold to defeat superbugs
In a modern take on the Victorian gold rush, a Monash University-led project is 'bioprospecting' for viruses known as phages that can kill deadly superbugs. [ + ]
Mechanical signalling may be key to plant regeneration
Researchers in Japan have discovered the mechanisms involved in plant cell regeneration and how the plants create the correct type of tissue when damaged. [ + ]
CSIRO telescope's new galaxy discovery causes questions
Researchers using a telescope owned by CSIRO have detected a 'fast radio burst' in a nearby galaxy that questions what we know about how the phenomena form. [ + ]
CUREator funds 19 new biotech projects
CUREator has announced its second round of funding, awarding $12 million to 19 projects targeting global health challenges. [ + ]